StudyGraphics #VisualAbstract: Topical calcineurin inhibitor use is associated with an increased risk of lymphoma May 26, 2021 | Teddy Guo Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Print Click to read the study in JAMA Dermatology. RELATED ARTICLESMORE FROM AUTHOR #Visual Abstract Watchful waiting may be an appropriate strategy for some patients with basal cell carcinomas #VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas #VisualAbstract: Post-induction chemotherapy Epstein-Barr virus DNA is an effective prognostic indicator for nasopharyngeal carcinomas
